The news is by your side.

Rahul Gandhi Slams Indo-US Trade Deal, Challenges PM Modi to Scrap It in Fiery Bhopal Speech

From Our Representative Bhopal: Congress leader and Leader of Opposition in the Lok Sabha, Rahul Gandhi, launched a blistering attack on Prime Minister Narendra Modi during a major farmers' rally here today, demanding the immediate scrapping of the recently signed Indo-US interim trade deal. Addressing the 'Kisan Maha Chaupal' organised by the Congress party, Gandhi accused the Prime Minister of compromising national interests, particularly those of farmers, under external pressure. The rally, attended by

India’s E-Commerce to Surge Over 2X, from $120–140 Billion Today to $280–300 Billion by 2030; Redefining the Future of Connected Commerce

NEW DELHI: India’s e-commerce market is entering a new phase, one defined not by competition between online and offline retail, but by their co-existence in a connected consumer journey. Shoppers today move seamlessly between screens and stores, researching online, purchasing offline, and vice versa, based on convenience, trust, and need. These are among the findings of a new report by Boston Consulting Group (BCG), $300 Billion Connected Commerce: How Clicks and Bricks Are Defining the Future of India’s E-Commerce,

Kotak Mahindra AMC Achieves New Peak with ₹6 Lakh Crore AUM, Driven by Nationwide Investor Trust

Mumbai: Kotak Mahindra Asset Management Company Limited (“KMAMC” / “Kotak Mutual Fund”) today announced that its Assets Under Management (AUM) have crossed ₹6 lakh crore as of the close of business on February 18, 2026. The milestone reflects the collective confidence and long‑term commitment of investors across the country and comes just over a year after the AMC crossed the ₹5 lakh crore mark on December 4, 2024. The steady progression in AUM underscores how investors have continued to stay invested and add

Akme Fintrade (India) Limited to raise ₹ 85.75 crore through preferential allotment of warrants

Mumbai: Akme Fintrade (India) Limited (AFIL) is looking to raise close to ₹ 85.75 crore through preferential issue of warrants. It plans to issue up to 12,25,00,000 convertible warrants into equivalent number of fully paid-up equity shares having Face Value of ₹ 1 each at a price of ₹ 7. The warrants will be convertible into equity shares in one or more tranches within a period of 18 months from the date of allotment of the Warrants. An amount equivalent to 25% of the consideration of the warrants would be payable at the

- Advertisement -

Alembic Pharmaceuticals Limited announces USFDA Final Approval for Efinaconazole Topical Solution

Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Efinaconazole Topical Solution, 10%. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Jublia Topical Solution, 10%, of Bausch Health Americas, Inc. (Bausch). Efinaconazole Topical Solution is indicated for the topical treatment of onychomycosis of the toenail(s) due to

Eye Care Tips during Holi

By Dr. Minal Kanhere, Consultant Cornea, Cataract and Refractive Surgeon, With the arrival of spring, Holi brings high spirits, happiness and positive energy. Holi is full of excitement and playful, colourful celebrations. This festival of colours, here are some precautions and safety tips on eye care: Use organic/natural colours: As far as possible, steer away from using artificial colours containing toxic and harsh chemicals which can cause damage to the eyes. Switch to herbal or organic colours which are safer.

Raising Awareness About Rare and Silent Cancers

By Dr Ranveer Singh Rana consultant surgical oncology Some cancers arrive without warning. They do not cause sharp pain or any other changes in the body in the initial stage. They settle quietly into the body, growing in places that are hard to see and even harder to suspect. These are often referred to as rare and silent cancers and their silence is what makes them dangerous. Across India, doctors and public health researchers have observed that a significant number of cancer diagnosis happens at a delayed stage, not

- Advertisement -

Economy

- Advertisement -

Politics

Entertainment

Technology

Lifestyle

Ayush

Sports

Education

Tourism